首页 > 抗体 > 兔单抗 > LATS1 Rabbit mAb
LATS1 Rabbit mAb
商品货号: PRM8251
适 应 性: 人,小鼠,大鼠
WB IF ELISA IP
¥800元
规格:
在线咨询
MSDS
说明书
商品描述
  • 发货日期: 现货
  • 靶点-Target: LATS1
  • 反应性-Reactivity: 人,小鼠,大鼠
  • 应用-Applications: WB,IF,IP,ELISA
  • MW(Calculated): 127kD
  • MW(Observed): 140kD
  • 宿主物种-Host Species: Rabbit
  • 同种型-Isotype: IgG,Kappa
  • 偶联-Conjugate: Unmodified
  • 推荐稀释比: WB 1:2000-1:10000;IF 1:200-1:1000;ELISA 1:5000-1:20000;IP 1:50-1:200;
  • 组成: PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
  • 纯化工艺: Protein A
  • 储存: -15°C to -25°C/1 year(Do not lower than -25°C)
  • 克隆性: Monoclonal
  • 克隆号: PT0609R
  • 特异性: Endogenous
  • 基因名称: LATS1 WARTS
  • 蛋白名称: Serine/threonine-protein kinase LATS1 (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)
  • 别名: Serine/threonine-protein kinase LATS1;Large tumor suppressor homolog 1;WARTS protein kinase;h-warts;
  • Organism-1: Human
  • 基因ID-1: 9113
  • SwissProt-1: O95835
  • Organism-2: Mouse
  • 基因ID-2: 16798
  • SwissProt-2: Q8BYR2
  • 背景: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatmen
  • 细胞定位: Cytoplasm
LATS1 Rabbit mAb
Catalog No PRM8251
Product information
  • 发货日期: 现货
  • 靶点-Target: LATS1
  • 反应性-Reactivity: 人,小鼠,大鼠
  • 应用-Applications: WB,IF,IP,ELISA
  • MW(Calculated): 127kD
  • MW(Observed): 140kD
  • 宿主物种-Host Species: Rabbit
  • 同种型-Isotype: IgG,Kappa
  • 偶联-Conjugate: Unmodified
  • 推荐稀释比: WB 1:2000-1:10000;IF 1:200-1:1000;ELISA 1:5000-1:20000;IP 1:50-1:200;
  • 组成: PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
  • 纯化工艺: Protein A
  • 储存: -15°C to -25°C/1 year(Do not lower than -25°C)
  • 克隆性: Monoclonal
  • 克隆号: PT0609R
  • 特异性: Endogenous
  • 基因名称: LATS1 WARTS
  • 蛋白名称: Serine/threonine-protein kinase LATS1 (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)
  • 别名: Serine/threonine-protein kinase LATS1;Large tumor suppressor homolog 1;WARTS protein kinase;h-warts;
  • Organism-1: Human
  • 基因ID-1: 9113
  • SwissProt-1: O95835
  • Organism-2: Mouse
  • 基因ID-2: 16798
  • SwissProt-2: Q8BYR2
  • 背景: The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatmen
  • 细胞定位: Cytoplasm
  • Hunan UPT Biotechnology Co.,Ltd
    Website:www.uptbio.com Servive hotline :4006916686
    E-mail:service@uptbio.com
    Address:
    Room 402, Building 13, Xinggong International Industrial Park, 100 Guyuan Road, Yuelu District, Changsha City, Hunan Province, China.
普拉特泽实验室电话助手

4006916686

扫码咨询